FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055665791> ?p ?o ?g. }

• W2055665791 endingPage "e0119765" @default.
• W2055665791 startingPage "e0119765" @default.
• W2055665791 abstract "The S100A8 and epidermal growth factor receptor (EGFR) proteins are proto-oncogenes that are strongly expressed in a number of cancer types. EGFR promotes cellular proliferation, differentiation, migration and survival by activating molecular pathways. Involvement of proinflammatory S100A8 in tumor cell differentiation and progression is largely unclear and not studied in kidney cancer (KC). S100A8 and EGFR are potential therapeutic biomarkers and anticancer drug targets for KC. In this study, we explored molecular mechanisms of interaction profiles of both molecules with potential anticancer drugs. We undertook transcriptional profiling in Saudi KCs using Affymetrix HuGene 1.0 ST arrays. We identified 1478 significantly expressed genes, including S100A8 and EGFR overexpression, using cut-off p value <0.05 and fold change ≥2. Additionally, we compared and confirmed our findings with expression data available at NCBI’s GEO database. A significant number of genes associated with cancer showed involvement in cell cycle progression, DNA repair, tumor morphology, tissue development, and cell survival. Atherosclerosis signaling, leukocyte extravasation signaling, notch signaling, and IL-12 signaling were the most significantly disrupted signaling pathways. The present study provides an initial transcriptional profiling of Saudi KC patients. Our analysis suggests distinct transcriptomic signatures and pathways underlying molecular mechanisms of KC progression. Molecular docking analysis revealed that the kinase inhibitor midostaurin has amongst the selected drug targets, the best ligand properties to S100A8 and EGFR, with the implication that its binding inhibits downstream signaling in KC. This is the first structure-based docking study for the selected protein targets and anticancer drug, and the results indicate S100A8 and EGFR as attractive anticancer targets and midostaurin with effective drug properties for therapeutic intervention in KC." @default.
• W2055665791 created "2016-06-24" @default.
• W2055665791 creator A5000747807 @default.
• W2055665791 creator A5004589445 @default.
• W2055665791 creator A5012811424 @default.
• W2055665791 creator A5032939334 @default.
• W2055665791 creator A5038416805 @default.
• W2055665791 creator A5047178680 @default.
• W2055665791 creator A5067955916 @default.
• W2055665791 creator A5078691075 @default.
• W2055665791 creator A5079573677 @default.
• W2055665791 date "2015-03-19" @default.
• W2055665791 modified "2023-09-25" @default.
• W2055665791 title "Molecular Interaction of a Kinase Inhibitor Midostaurin with Anticancer Drug Targets, S100A8 and EGFR: Transcriptional Profiling and Molecular Docking Study for Kidney Cancer Therapeutics" @default.
• W2055665791 cites W1501199419 @default.
• W2055665791 cites W1516074990 @default.
• W2055665791 cites W1523413020 @default.
• W2055665791 cites W1591103902 @default.
• W2055665791 cites W1591263613 @default.
• W2055665791 cites W173643440 @default.
• W2055665791 cites W1827743777 @default.
• W2055665791 cites W184793376 @default.
• W2055665791 cites W1878762030 @default.
• W2055665791 cites W1965186367 @default.
• W2055665791 cites W1967060390 @default.
• W2055665791 cites W1971681203 @default.
• W2055665791 cites W1974024530 @default.
• W2055665791 cites W1988063410 @default.
• W2055665791 cites W1993300766 @default.
• W2055665791 cites W1994973292 @default.
• W2055665791 cites W1995089537 @default.
• W2055665791 cites W1995242599 @default.
• W2055665791 cites W1996939905 @default.
• W2055665791 cites W1997374162 @default.
• W2055665791 cites W2002937040 @default.
• W2055665791 cites W2003066989 @default.
• W2055665791 cites W2006664904 @default.
• W2055665791 cites W2010448953 @default.
• W2055665791 cites W2014593841 @default.
• W2055665791 cites W2015272087 @default.
• W2055665791 cites W2020509469 @default.
• W2055665791 cites W2030205108 @default.
• W2055665791 cites W2030517487 @default.
• W2055665791 cites W2033601733 @default.
• W2055665791 cites W2034269086 @default.
• W2055665791 cites W2036785342 @default.
• W2055665791 cites W2041278117 @default.
• W2055665791 cites W2043696829 @default.
• W2055665791 cites W2049319639 @default.
• W2055665791 cites W2049639992 @default.
• W2055665791 cites W2061445292 @default.
• W2055665791 cites W2073205505 @default.
• W2055665791 cites W2073206600 @default.
• W2055665791 cites W2076297869 @default.
• W2055665791 cites W2081438440 @default.
• W2055665791 cites W2086012388 @default.
• W2055665791 cites W2091075436 @default.
• W2055665791 cites W2094883982 @default.
• W2055665791 cites W2097976367 @default.
• W2055665791 cites W2103830385 @default.
• W2055665791 cites W2105668062 @default.
• W2055665791 cites W2111463022 @default.
• W2055665791 cites W2117022661 @default.
• W2055665791 cites W2117692326 @default.
• W2055665791 cites W2123404680 @default.
• W2055665791 cites W2123859926 @default.
• W2055665791 cites W2126372596 @default.
• W2055665791 cites W2127268499 @default.
• W2055665791 cites W2129556489 @default.
• W2055665791 cites W2133671622 @default.
• W2055665791 cites W2139369020 @default.
• W2055665791 cites W2139584581 @default.
• W2055665791 cites W2144578507 @default.
• W2055665791 cites W2147421370 @default.
• W2055665791 cites W2154625299 @default.
• W2055665791 cites W2158534713 @default.
• W2055665791 cites W2161817637 @default.
• W2055665791 cites W2161888715 @default.
• W2055665791 cites W2166344128 @default.
• W2055665791 cites W2317301418 @default.
• W2055665791 cites W4244640572 @default.
• W2055665791 cites W4244954924 @default.
• W2055665791 cites W57081243 @default.
• W2055665791 doi "https://doi.org/10.1371/journal.pone.0119765" @default.
• W2055665791 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4366044" @default.
• W2055665791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25789858" @default.
• W2055665791 hasPublicationYear "2015" @default.
• W2055665791 type Work @default.
• W2055665791 sameAs 2055665791 @default.
• W2055665791 citedByCount "17" @default.
• W2055665791 countsByYear W20556657912016 @default.
• W2055665791 countsByYear W20556657912017 @default.
• W2055665791 countsByYear W20556657912018 @default.
• W2055665791 countsByYear W20556657912019 @default.
• W2055665791 countsByYear W20556657912020 @default.
• W2055665791 countsByYear W20556657912022 @default.
• W2055665791 countsByYear W20556657912023 @default.
• W2055665791 crossrefType "journal-article" @default.

• next